Transitions of multifocal electroretinography in patients with age-related macular degeneration after combination therapy with photodynamic therapy and intravitreal bevacizumab

Documenta Ophthalmologica

Volumn 119, Issue 3, 2009, Pages 163-169

  Liu, Yan ^a   Wen, Feng ^b   Li, Jiaqing ^b   Zuo, Chengguo ^b   Li, Meng ^b  

^a FUDAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Bevacizumab; Choroidal neovascularization; Multifocal electroretinography; Photodynamic therapy

Indexed keywords

BEVACIZUMAB; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DRUG THERAPY, COMBINATION; ELECTRORETINOGRAPHY; EYE; FEMALE; HUMANS; INJECTIONS, INTRAOCULAR; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TIME FACTORS;

EID: 71349084222     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-009-9189-2     Document Type: Article

References (20)

1. R Klein BE Klein SC Jensen SM Meuer 1997 The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 104 7 21 1:STN:280:DyaK2s7nsVeltg%3D%3D 9022098 (Pubitemid 27081937)
2. Kaiser PK (2006) Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8. Graefes Arch Clin Exp Ophthalmol 244:1132-1142
3. M Matsuoka N Ogata T Otsuji T Nishimura K Takahashi M Matsumura 2004 Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy Br J Ophthalmol 88 809 815 10.1136/bjo.2003.032466 1:STN:280: DC%2BD2c3kvFKrsw%3D%3D 15148217 (Pubitemid 38725593)
4. U Schmidt-Erfurth U Schlötzer-Schrehard C Cursiefen S Michels A Beckendorf GO Naumann 2003 Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 4473 4480 10.1167/iovs.02-1115 14507895 (Pubitemid 37186285)
5. ID Ladas AI Kotsolis TD Papakostas AA Rouvas DA Karagiannis I Vergados 2007 Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration Retina 27 891 896 10.1097/IAE.0b013e3180ca9ad9 17891013 (Pubitemid 47479383)
6. RA Costa R Jorge D Calucci LA Melo Jr JA Cardillo IU Scott 2007 Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study) Graefes Arch Clin Exp Ophthalmol 245 1273 1280 10.1007/s00417-007-0557-x 1:CAS:528:DC%2BD2sXptVGms78%3D 17333238 (Pubitemid 47278663)
7. BT Smith MS Dhalla GK Shah KJ Blinder EH Ryan Jr RA Mittra 2008 Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration Retina 28 675 681 10.1097/IAE.0b013e31816b316e 18463509 (Pubitemid 351655118)
8. G Weigert S Michels S Sacu A Varga F Prager W Geitzenauer U Schmidt-Erfurth 2008 Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study Br J Ophthalmol 92 356 360 10.1136/bjo.2007.125823 1:STN:280:DC%2BD1c7ktlOgtw%3D%3D 18303156
9. R Lazic N Gabric 2007 Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration Ophthalmology 114 1179 1185 10.1016/j.ophtha.2007.03.006 17544776 (Pubitemid 46829388)
10. B Feigl J Lovie-Kitchin B Brown 2005 Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram Clin Exp Optom 88 304 312 16255689
11. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 117:1329-1345
12. DC Hood M Bach M Brigell, et al. 2008 ISCEV guidelines for clinical multifocal electroretinography (2007 edition) Doc Ophthalmol 116 1 11 10.1007/s10633-007-9089-2 17972125
13. B Jurklies M Weismann J Hüsing EE Sutter N Bornfeld 2002 Monitoring retinal function in neovascular maculopathy using multifocal electroretinography-early and long-term correlation with clinical findings Graefes Arch Clin Exp Ophthalmol 240 244 264 10.1007/s00417-002-0439-1 1:STN:280:DC%2BD383ktlWntw%3D%3D 11981638 (Pubitemid 36075593)
14. AM Mackay MC Brown RP Hagan AC Fisher I Grierson SP Harding 2007 Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy Doc Ophthalmol 115 69 76 10.1007/s10633-007-9056-y 17671804 (Pubitemid 47412799)
15. MM Moschos D Panayotidis G Theodossiadis M Moschos 2004 Assessment of macular function by multifocal electroretinogram in age-related macular degeneration before and after photodynamic therapy J Fr Ophtalmol 27 1001 1006 10.1016/S0181-5512(04)96255-9 1:STN:280:DC%2BD2crot12rtQ%3D%3D 15557861
16. TY Lai WM Chan DS Lam 2004 Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy Am J Ophthalmol 137 826 833 10.1016/j.ajo.2003.11.079 15126146 (Pubitemid 38582034)
17. L Arias JM Caminal L Casas C Masuet MB Badia M Rubio O Pujol J Arruga 2008 A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Br J Ophthalmol 92 1636 1641 10.1136/bjo.2008.141721 1:STN:280:DC%2BD1cjlsF2nug%3D%3D 18782803
18. MI Roh HS Kim JH Song JB Lim OW Kwon 2009 Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema Ophthalmology 116 80 86 10.1016/j.ophtha.2008.09.036 19118699
19. MM Moschos M Moschos 2008 Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study Doc Ophthalmol 116 147 152 10.1007/s10633-007-9110-9 18189152
20. H Imai S Honda Y Nakanishi H Yamamoto Y Tsukahara A Negi 2006 Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy Br J Ophthalmol 90 1524 1530 10.1136/bjo.2006.092783 1:STN:280:DC%2BD28nnsVyiug%3D%3D 16825279 (Pubitemid 44862575)